Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
schizophrenia, Food and Drug Administration
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
US FDA clears Cobenfy, first new schizophrenia drug in decades
The FDA has approved Cobenfy, a dual M1/M4 muscarinic agonist that offers a fundamentally different approach to treating schizophrenia. The fixed dose combination of xanomeline-trospium is the first to act via a novel mechanism for the serious psychiatric disorder in over 50 years,
In a Victory for the Free Market, FDA Approves New Schizophrenia Drug
The U.S. Food and Drug Administration (FDA) approved a novel antipsychotic schizophrenia drug late Thursday, marking the first new treatment in decades for the mental health condition that affects 1.8 percent of the U.
FDA approves 1st new drug to treat schizophrenia in more than 30 years
This drug takes the first new approach to schizophrenia treatment in decades," Farchione continued. "This approval offers a new alternative to the antipsychotic medications peo
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.
FDA Approves New Kind of Drug for Schizophrenia
For decades, people with schizophrenia have only had one major form of medication to help quell disturbing symptoms. On Thursday, the FDA approved Cobenfy, the firs
Valley Public Radio
5m
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
11h
on MSN
New schizophrenia drug could ‘change the lives of millions of people’
The US Food and Drug Administration has approved the new drug Cobenfy, which is owned by pharmaceutical firm Bristol Myers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
High-end brothel plea
Helene: How to help
'Harry Potter' star dies
Troops to leave some bases
Stadiums to serve as shelters
Promotes watch collection
Targeted Black residents?
World's oldest cheese found
Killer gets life sentence
50/50 ball ownership suit
On Secret Service failures
NIH finds misconduct
Producing doc on Diddy
Urgent safety alert for 737s
US charges three Iranians
Ending password-sharing
Chinese submarine sank
Boxes to distribute Narcan
Pleads not guilty
NC board removes 747K
WI duplicate ballot flap
Fake Biden robocalls fine
ISR targets Hezbollah HQ
More executives leave
Heads to US-Mexico border
Fed inflation gauge cools
Meta hit with privacy fine
Feedback